Evidence map›Paper›PMID 41348117›Full record

ArticleMicrobiology (Reading, England)2025

Cas9 modulates

Chinmoy Saha, Dior Beerens, Peter van Baarlen, Rogier Louwen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology (Reading, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Cas9 modulatesMicrobiology (Reading, England) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chinmoy SahaDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands.
Dior BeerensDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands.
Peter van BaarlenHost-Microbe Interactomics Group, Wageningen University, Wageningen, Netherlands.
Rogier LouwenDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The CRISPR-associated protein 9 (Cas9) produced by disease-associated strains of

Indexed as

Bacterial ProteinsCampylobacter jejuniCRISPR-Associated Protein 9Epithelial CellsAnti-Bacterial AgentsCaco-2 CellsCampylobacter InfectionsCiprofloxacinHumansLipopolysaccharidesToll-Like Receptor 2VirulenceVirulence FactorsAnti-Bacterial AgentsBacterial ProteinsCiprofloxacinCRISPR-Associated Protein 9LipopolysaccharidesTLR2 protein, humanToll-Like Receptor 2Virulence FactorsCaco-2Campylobacter jejuniCas9cell envelopeciprofloxacinsurvivalTLR-2

Identifiers

PMID41348117
PMCPMC12690155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.